| Year | 2022 |
|---|---|
| Authors | PING-HSUN CHEN |
| Paper Title | Ping-Hsun Chen*, 2022.10, 'How a Dosage Regimen Patent for RRMS Treatment May Satisfy the Written Description Requirement—A Lesson from Novartis Pharmaceuticals Corp. v. Accord Healthcare, Inc., ' Biotechnology Law Report, Vol.41, No.5, pp.240-250.(SCIE)(*為通訊作者) |
| Vol.No | 440831 |
| Date of Publication | 2022-10-01 |
Login NCCU College of Commerce
